[Willingness to receive the COVID-19 vaccine in the population aged 80 years and older in Colombia 2021].
Disposición a recibir la vacuna contra COVID-19 en población de 80 y más años en Colombia 2021.
COVID-19
Colombia
SARS-Cov-2
Vaccines
Journal
Vacunas
ISSN: 1576-9887
Titre abrégé: Vacunas
Pays: Spain
ID NLM: 101528857
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
received:
17
03
2021
accepted:
23
07
2021
pubmed:
10
8
2021
medline:
10
8
2021
entrez:
9
8
2021
Statut:
ppublish
Résumé
Colombia designed and adopted a vaccination plan against COVID-19 that will immunize 35 million people. The aim study was to know the willingness to accept the vaccination against COVID-19. A telephone survey of 11,721 people aged 80 and over, affiliated with a health insurer, was carried. The respondents were the affiliates or their relatives or caregivers. The average age was 85.0 years (SD: 4.5), with no differences between sexes; 3,344 (28.5%) referred a previous diagnostic test for COVID-19 and 73 were positive for an incidence of 622.8 per 100,000 people (95%CI: 491-778). Regarding the attitude with the vaccination against SARS-CoV-2, 1/4 respondents refrained from giving an opinion or was neutral. When the respondent was a relative, the acceptance of the vaccine was 60.4% (95% CI: 59.5-61.3) with differences by gender: men 62.2% (95% CI: 60.8-63.6) and women of 59.2 (95% CI: 58.0-60.3), The relatively low acceptance of vaccination against COVID-19 in Colombia poses significant challenges to achieve herd immunity that allows control of the pandemic.
Identifiants
pubmed: 34366753
doi: 10.1016/j.vacun.2021.07.005
pii: S1576-9887(21)00045-5
pmc: PMC8332929
doi:
Types de publication
English Abstract
Journal Article
Langues
spa
Pagination
S41-S45Informations de copyright
© 2021 Published by Elsevier España, S.L.U.
Références
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
Vaccine. 2003 Oct 1;21(27-30):4105-17
pubmed: 14505886
Adv Exp Med Biol. 2011;697:1-8
pubmed: 21120715
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Int J Infect Dis. 2020 Oct;99:522-529
pubmed: 32791206
Vaccines (Basel). 2020 Dec 30;9(1):
pubmed: 33396832
EClinicalMedicine. 2020 Sep;26:100495
pubmed: 32838242